Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rocket Pharmaceuticals, Inc. - Common Stock
(NQ:
RCKT
)
3.510
+0.030 (+0.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rocket Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Rocket Pharmaceuticals to Participate in the 43rd Annual Cowen Health Care Conference
March 01, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharma COO On Observing Rare Disease Day, And Why It Deserves US Attention
↗
February 28, 2023
Feb. 28 is Rare Disease Day. It's meant to observe the more than 400 million people globally — 50% of them children — that are affected by rare, pediatric life-threatening diseases such as leukemia,...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Rocket Pharmaceuticals
↗
February 28, 2023
Via
Benzinga
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial and Operational Results
February 27, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
The Latest Analyst Ratings for Rocket Pharmaceuticals
↗
January 23, 2023
Via
Benzinga
Where Rocket Pharmaceuticals Stands With Analysts
↗
December 06, 2022
Via
Benzinga
Expert Ratings for Rocket Pharmaceuticals
↗
December 06, 2022
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Rocket Pharmaceuticals: Here's What You Need To Know
↗
December 06, 2022
Via
Benzinga
Rocket Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
February 09, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease
February 07, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
↗
February 01, 2023
Via
Benzinga
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon Disease
January 09, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
↗
December 23, 2022
Gainers
Via
Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
↗
December 23, 2022
Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market...
Via
Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
↗
December 22, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
↗
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
↗
December 22, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Via
Benzinga
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
December 22, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Completes Acquisition of Renovacor
December 01, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 28, 2022
Via
Benzinga
Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket
↗
November 28, 2022
Gainers Talkspace, Inc. (NASDAQ: TALK) shares rose 48.3% to $0.89 in pre-market trading. Talkspace recently named Jon Cohen as CEO.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
November 28, 2022
Welcome back, trader! It's time to check out the biggest pre-market stock movers that traders will want to know about on Monday!
Via
InvestorPlace
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
↗
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
↗
November 15, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
↗
November 08, 2022
Upgrades
Via
Benzinga
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
